Literature DB >> 14392948

Reticulosis of the nervous system simulating acute infective polyneuritis.

R S ALLISON, D S GORDON.   

Abstract

Entities:  

Keywords:  CENTRAL NERVOUS SYSTEM/neoplasms; GUILLAIN-BARRE SYNDROME/complications; LYMPHOMA; SARCOMA, RETICULUM CELL

Mesh：

Year:  1955        PMID： 14392948     DOI： 10.1016/s0140-6736(55)92119-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  [On the clinical aspects and morphology of the so-called "advential sarcoma"].

Authors:  B Bingas; K J Zülch
Journal:  Acta Neurochir (Wien)       Date:  1966       Impact factor: 2.216

2.  Peripheral neuropathy with distal nerve infiltration revealing a diffuse pleiomorphic malignant lymphoma.

Authors:  M Zuber; R Gherardi; M Imbert; P Gaulard; M Kuentz; J Poirier
Journal:  J Neurol       Date:  1987-10       Impact factor: 4.849

Review 3.  Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification.

Authors:  C Vital; A Vital; J Julien; J Rivel; A deMascarel; B Vergier; P Henry; M Barat; J Reiffers; A Broustet
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

4.  Neuropathy associated with lymphoma.

Authors:  J C Walsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

5.  Primary meningeal B lymphoma presenting as a subacute ascending polyradiculoneuropathy.

Authors:  J Julien; C Vital; J Rivel; A de Mascarel; A Lagueny; X Ferrer; B Vergier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

Review 6.  Primary central nervous system lymphoma with systemic metastasis: case report and review.

Authors:  M T Brown; R E McClendon; J P Gockerman
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Involvement of the nervous system in malignant lymphoma in Nigeria.

Authors:  I Janota
Journal:  Br J Cancer       Date:  1966-03       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.